Bioxytran BIXT
OTC BIXT
$0.02 +0.00 (+1.85%)
As of: Aug 21, 2026 · 11:03 AM EDT

Bioxytran (BIXT) Amortizatization of Intangibles (2019 - 2024)

Bioxytran (BIXT) posted Amortizatization of Intangibles of $622781.0 for Q4 2024, up 2391.12% sequentially from $25000.0 in Q3 2024.

Bioxytran (BIXT) Amortizatization of Intangibles (2019 - 2024) Analysis & Trends

Bioxytran has reported Amortizatization of Intangibles for 5 years, with the latest figure at $622781.0 in Q4 2024.

  • Quarterly Amortizatization of Intangibles changed N/A year-over-year to $622781.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $647781.0 (up 247.44% YoY) and the FY2024 annual result came in at $677781.0, up 94.41% from the prior year.
  • Amortizatization of Intangibles improved to $622781.0 in Q4 2024 per BIXT's latest filing, from $25000.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $622781.0 in Q4 2024 and troughed at $1000.0 in Q3 2020.
  • A 4-year average of $115536.4 and a median of $41425.0 in 2022 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2020 and 2021: Amortizatization of Intangibles tumbled 92.75% in 2020, then surged 2896.4% in 2021.
  • Over 4 years, Amortizatization of Intangibles stood at $1000.0 in 2020, then soared by 2896.4% to $29964.0 in 2021, then tumbled by 52.4% to $14263.0 in 2022, then soared by 4266.41% to $622781.0 in 2024.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $622781.0, $25000.0, and $14263.0 for Q4 2024, Q3 2024, and Q4 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Bioxytran 2.52 Mn 2.27 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 622,781.00
Dec 31, 2024 622,781.00
Sep 30, 2024 25,000.00
Sep 30, 2024 25,000.00
Dec 31, 2022 14,263.00
Dec 31, 2022 14,263.00
Sep 30, 2022 172,182.00
Sep 30, 2022 172,182.00
Jun 30, 2022 41,425.00
Jun 30, 2022 41,425.00
Mar 31, 2022 91,334.00
Mar 31, 2022 91,334.00
Dec 31, 2021 29,964.00
Dec 31, 2021 29,964.00
Sep 30, 2021 29,964.00
Sep 30, 2021 29,964.00
Sep 30, 2020 1,000.00
Sep 30, 2020 1,000.00
Jun 30, 2020 76,265.00
Jun 30, 2020 76,265.00